Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for RMBI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain dividend at $0.15 per share quarterly | A primary condition in RICHMOND MUTUAL BANCORPORATION INC's published investment case. The stated target is >= $0.15 per share per quarter. | Intact | dividend per share falls below $0.15 next quarter | Dividend per share: $0.15 per share FY2026-Q2; GAAP. Published target: >= $0.15 per share per quarter. The target does not explicitly identify fiscal versus calendar quarters. Aug 13, 20260.15 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking business with a merger-integration story, rather than a clear turnaround or high-growth case. The long-term thesis is still developing: the Farmers Bancorp merger is complete, but evidence on the combined company’s performance remains limited.
RMBI is described as cheap versus peers, with a small negative expectations gap, meaning market expectations appear slightly more cautious than the valuation model’s view. The overall priced-in assessment is tagged justified, and no fragility gates fired, so the evidence does not point to unusually concentrated expectations.
Near term, net interest income and net interest margin improved from the first to the second quarter of 2026, while revenue was described as stable; management’s focus on these areas is on track. The latest earnings changed the signal from mildly favorable to mixed, and a guidance cut on the next call is a stated risk. Over the multi-year view, integration and synergy realization remain important, but the evidence on results after the merger is still thin.
The thesis hinges on whether management integrates Farmers Bancorp and realizes synergies while sustaining revenue stability and margin expansion. Near term, a guidance cut or Fed rate cuts would be unfavorable factors; continued strong earnings and higher guidance from financial-sector peers would support sector momentum.
For the next 1 to 3 years, RMBI’s thesis has some support from improving interest income and a completed merger, but fresh results are mixed and the combined company’s trajectory is not yet well established. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Achieve EPS of at least $1.17 in FY26 and $2.00 in Q2 2026 | A primary condition in RICHMOND MUTUAL BANCORPORATION INC's published investment case. The stated target is EPS >= $1.17 FY26 and EPS >= $2.00 Q2 2026. | Broken | EPS falls below $1.17 for FY26 or below $2.00 for Q2 2026 | Diluted EPS: $0.22 per share FY2026-Q2; GAAP. Published target: EPS >= $1.17 FY26 and EPS >= $2.00 Q2 2026. Target period is not explicitly aligned with this observation. Aug 13, 20260.22 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful integration of The Farmers Bancorp merger | A supporting condition in RICHMOND MUTUAL BANCORPORATION INC's published investment case. The stated target is Merger fully integrated without major legal or operational issues. | Improving | Merger faces major legal setbacks or operational failures | Merger completed 2026-08-12; no legal/operational issues reported Acquisition completed Aug 12, 2026; Q3 earnings released Oct 30, 2026; no negative merger news. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Keep revenue stable near $21.8 million quarterly | Revenue stays steady near $21.8 million. | Broken | quarterly revenue falls below $20 million next year | Revenue: $21.899M FY2026-Q2; GAAP. Published target: >= $21.8 million quarterly. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 13, 202621,898,601 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.